An outbreak and isolation of drug-resistant Pseudomonas aeruginosa at Niigata University Hospital, Japan

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
Ritsuko SatohFumitake Gejyo

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that causes disease in patients with impaired host defenses; it is often a cause of life-threatening nosocomial infection in critically ill and immunocompromised patients. An increase in the prevalence of multiple-drug-resistant Pseudomonas aeruginosa (MDRP) in hospitals is thus a worldwide problem. These increases are frequently related to the high selective pressure of antimicrobials commonly used in hospitalized patients, particularly extended-spectrum cephalosporins, beta-lactamase-inhibitor combinations, carbapenems, fluoroquinolones, and aminoglycosides. We evaluated the clinical and microbiological characteristics of drug-resistant P. aeruginosa and MDRP strains that were isolated at Niigata University Hospital, Japan, from 2000 to 2004. We experienced an outbreak of MDRP in 2000, but colonization only was the main feature of the outbreak. Also, the isolation rate of MDRP has decreased since 2004; this reduction in the isolation rate seems to be a result of a move to newly built ward sections in 2001 and the establishment of an infection control team (ICT) in 2003.

References

Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A HarrisY Carmeli
Apr 13, 2005·Respirology : Official Journal of the Asian Pacific Society of Respirology·Kazushi MotomuraTsuyoshi Nagatake
Dec 20, 2005·Scandinavian Journal of Infectious Diseases·Jonas HedlundUNKNOWN Community-Acquired Pneumonia Working Group of the Swedish Society of Infectious Diseases

❮ Previous
Next ❯

Citations

Aug 7, 2012·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Katsuhiro FuseAkira Watanabe
Mar 19, 2014·Nursing & Health Sciences·Kazumi Kawakami, Hanako Misao
Aug 1, 2019·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Masachika SaekiSatoshi Takahashi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.